Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Knowledge of current abortion law and views on abortion law reform: a community survey of NSW residents.

Barratt AL, McGeechan K, Black KI, Hamblin J, de Costa C.

Aust N Z J Public Health. 2018 Sep 10. doi: 10.1111/1753-6405.12825. [Epub ahead of print]

PMID:
30198605
2.

Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.

Nickel B, Howard K, Brito JP, Barratt A, Moynihan R, McCaffery K.

JAMA Otolaryngol Head Neck Surg. 2018 Aug 22. doi: 10.1001/jamaoto.2018.1694. [Epub ahead of print]

PMID:
30140909
3.

Renaming low risk conditions labelled as cancer.

Nickel B, Moynihan R, Barratt A, Brito JP, McCaffery K.

BMJ. 2018 Aug 12;362:k3322. doi: 10.1136/bmj.k3322. No abstract available.

PMID:
30100549
4.

Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.

Degeling C, Barratt A, Aranda S, Bell R, Doust J, Houssami N, Hersch J, Sakowsky R, Entwistle V, Carter SM.

BMJ Open. 2018 Jun 14;8(6):e021174. doi: 10.1136/bmjopen-2017-021174.

5.

Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study.

Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K.

BMC Cancer. 2018 Mar 2;18(1):242. doi: 10.1186/s12885-018-4152-9.

6.

Population attributable fractions of perinatal outcomes for nulliparous women associated with overweight and obesity, 1990-2014.

Cheney K, Farber R, Barratt AL, McGeechan K, de Vries B, Ogle R, Black KI.

Med J Aust. 2018 Feb 19;208(3):119-125.

PMID:
29438637
7.

"Thank You for Giving Me a Voice!" A Longitudinal Evaluation of Patients' Experience of Partnering With Students in an Australian Medical School.

Ivory KD, Luscombe G, Klein LA, Barratt A.

J Med Educ Curric Dev. 2017 Mar 15;4:2382120517692776. doi: 10.1177/2382120517692776. eCollection 2017 Jan-Dec.

8.

Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis.

Thomas ET, Del Mar C, Glasziou P, Wright G, Barratt A, Bell KJL.

BMC Cancer. 2017 Dec 2;17(1):808. doi: 10.1186/s12885-017-3808-1. Review.

9.

Reform of the National Screening Mammography Program in France.

Barratt A, Jørgensen KJ, Autier P.

JAMA Intern Med. 2018 Feb 1;178(2):177-178. doi: 10.1001/jamainternmed.2017.5836. No abstract available.

PMID:
29084317
10.

How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.

Hersch J, McGeechan K, Barratt A, Jansen J, Irwig L, Jacklyn G, Houssami N, Dhillon H, McCaffery K.

BMJ Open. 2017 Oct 6;7(10):e016246. doi: 10.1136/bmjopen-2017-016246.

11.

Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.

Jacklyn G, Morrell S, McGeechan K, Houssami N, Irwig L, Pathmanathan N, Barratt A.

Breast. 2018 Feb;37:170-178. doi: 10.1016/j.breast.2017.08.005. Epub 2017 Sep 5.

PMID:
28882419
12.

Avoiding harm and supporting autonomy are under-prioritised in cancer-screening policies and practices.

Parker L, Carter S, Williams J, Pickles K, Barratt A.

Eur J Cancer. 2017 Nov;85:1-5. doi: 10.1016/j.ejca.2017.07.056. Epub 2017 Sep 4.

PMID:
28881246
13.

"Standard Care" in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trials.

Dear RF, McGeechan K, Barnet MB, Barratt AL, Tattersall MHN.

J Natl Compr Canc Netw. 2017 Sep;15(9):1131-1139. doi: 10.6004/jnccn.2017.7012.

PMID:
28874598
14.

Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.

Jacklyn G, McGeechan K, Irwig L, Houssami N, Morrell S, Bell K, Barratt A.

Breast Cancer Res Treat. 2017 Dec;166(3):843-854. doi: 10.1007/s10549-017-4443-x. Epub 2017 Aug 19.

PMID:
28822001
15.

What is overdiagnosis and why should we take it seriously in cancer screening?

Carter SM, Barratt A.

Public Health Res Pract. 2017 Jul 26;27(3). pii: 2731722. doi: 10.17061/phrp2731722.

16.

Words do matter: a systematic review on how different terminology for the same condition influences management preferences.

Nickel B, Barratt A, Copp T, Moynihan R, McCaffery K.

BMJ Open. 2017 Jul 10;7(7):e014129. doi: 10.1136/bmjopen-2016-014129. Review.

17.

Impact of extending screening mammography to older women: Information to support informed choices.

Jacklyn G, Howard K, Irwig L, Houssami N, Hersch J, Barratt A.

Int J Cancer. 2017 Oct 15;141(8):1540-1550. doi: 10.1002/ijc.30858. Epub 2017 Jul 10. Erratum in: Int J Cancer. 2017 Dec 15;141(12 ):E8.

PMID:
28662267
18.

Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.

Nickel B, Brito JP, Barratt A, Jordan S, Moynihan R, McCaffery K.

Thyroid. 2017 May;27(5):661-671. doi: 10.1089/thy.2016.0483. Epub 2017 Mar 21.

PMID:
28322617
19.

Overview of guidelines on breast screening: Why recommendations differ and what to do about it.

Jørgensen KJ, Kalager M, Barratt A, Baines C, Zahl PH, Brodersen J, Harris RP.

Breast. 2017 Feb;31:261-269. doi: 10.1016/j.breast.2016.08.002. Epub 2016 Oct 4. Review.

PMID:
27717717
20.

A definition and ethical evaluation of overdiagnosis: response to commentaries.

Carter SM, Doust J, Degeling C, Barratt A.

J Med Ethics. 2016 Nov;42(11):722-724. doi: 10.1136/medethics-2016-103822. Epub 2016 Aug 29.

PMID:
27573152
21.

Performing (heterosexual) femininity: female agency and role in sexual life and contraceptive use - a qualitative study in Australia.

Kelly M, Inoue K, Barratt A, Bateson D, Rutherford A, Richters J.

Cult Health Sex. 2017 Feb;19(2):240-255. doi: 10.1080/13691058.2016.1214872. Epub 2016 Aug 23.

PMID:
27550536
22.

A definition and ethical evaluation of overdiagnosis.

Carter SM, Degeling C, Doust J, Barratt A.

J Med Ethics. 2016 Nov;42(11):705-714. doi: 10.1136/medethics-2015-102928. Epub 2016 Jul 8.

PMID:
27402883
23.

Doctors' experience of the contraceptive consultation: a qualitative study in Australia.

Kelly M, Inoue K, Black KI, Barratt A, Bateson D, Rutherford A, Stewart M, Richters J.

J Fam Plann Reprod Health Care. 2017 Apr;43(2):119-125. doi: 10.1136/jfprhc-2015-101356. Epub 2016 May 12.

PMID:
27172879
24.

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.

Jacklyn G, Glasziou P, Macaskill P, Barratt A.

Br J Cancer. 2016 May 24;114(11):1269-76. doi: 10.1038/bjc.2016.90. Epub 2016 Apr 28.

25.

Australian women's attitudes towards and understandings of the subdermal contraceptive implant: a qualitative study of never-users.

Inoue K, Kelly M, Barratt A, Bateson D, Rutherford A, Black KI, Stewart M, Richters J.

J Fam Plann Reprod Health Care. 2017 Apr;43(2):128-134. doi: 10.1136/jfprhc-2014-101132. Epub 2016 Mar 3.

PMID:
26941357
26.

Walking the tightrope: communicating overdiagnosis in modern healthcare.

McCaffery KJ, Jansen J, Scherer LD, Thornton H, Hersch J, Carter SM, Barratt A, Sheridan S, Moynihan R, Waller J, Brodersen J, Pickles K, Edwards A.

BMJ. 2016 Feb 5;352:i348. doi: 10.1136/bmj.i348. No abstract available.

PMID:
26850726
27.

Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease Detection.

Ingles J, Burns C, Barratt A, Semsarian C.

Circ Cardiovasc Genet. 2015 Dec;8(6):852-9. doi: 10.1161/CIRCGENETICS.115.001093. Review. No abstract available.

PMID:
26671970
28.

The importance of enabling informed decision making for women considering breast cancer screening.

Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, Thornton H, Dhillon H, Houssami N, McCaffery K.

J Med Screen. 2016 Mar;23(1):55. doi: 10.1177/0969141315612818. Epub 2015 Nov 17. No abstract available.

PMID:
26582494
29.

Perspective: The risks of overdiagnosis.

Barratt A.

Nature. 2015 Nov 19;527(7578):S104. doi: 10.1038/527S104a. No abstract available.

PMID:
26580156
30.

How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.

McCaffery K, Nickel B, Moynihan R, Hersch J, Teixeira-Pinto A, Irwig L, Barratt A.

BMJ Open. 2015 Nov 2;5(11):e008094. doi: 10.1136/bmjopen-2015-008094.

31.

How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.

Nickel B, Barratt A, Hersch J, Moynihan R, Irwig L, McCaffery K.

Breast. 2015 Oct;24(5):673-9. doi: 10.1016/j.breast.2015.08.004. Epub 2015 Sep 12.

PMID:
26376460
32.

Can consumers learn to ask three questions to improve shared decision making? A feasibility study of the ASK (AskShareKnow) Patient-Clinician Communication Model(®) intervention in a primary health-care setting.

Shepherd HL, Barratt A, Jones A, Bateson D, Carey K, Trevena LJ, McGeechan K, Del Mar CB, Butow PN, Epstein RM, Entwistle V, Weisberg E.

Health Expect. 2016 Oct;19(5):1160-8. doi: 10.1111/hex.12409. Epub 2015 Sep 14.

33.

Screening for Cervical, Prostate, and Breast Cancer: Interpreting the Evidence.

Carter SM, Williams J, Parker L, Pickles K, Jacklyn G, Rychetnik L, Barratt A.

Am J Prev Med. 2015 Aug;49(2):274-85. doi: 10.1016/j.amepre.2015.01.009. Epub 2015 Jun 16. Review.

PMID:
26091929
34.

Public Opinions about Overdiagnosis: A National Community Survey.

Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K.

PLoS One. 2015 May 20;10(5):e0125165. doi: 10.1371/journal.pone.0125165. eCollection 2015.

35.

What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians.

Moynihan R, Nickel B, Hersch J, Doust J, Barratt A, Beller E, McCaffery K.

BMJ Open. 2015 May 19;5(5):e007436. doi: 10.1136/bmjopen-2014-007436.

36.

Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.

Barratt A.

BMJ. 2015 Mar 3;350:h867. doi: 10.1136/bmj.h867. No abstract available.

PMID:
25736426
37.

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.

Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, Thornton H, Dhillon H, Houssami N, McCaffery K.

Lancet. 2015 Apr 25;385(9978):1642-52. doi: 10.1016/S0140-6736(15)60123-4. Epub 2015 Feb 18. Erratum in: Lancet. 2015 Apr 25;385(9978):1622.

PMID:
25701273
38.

Does research into contraceptive method discontinuation address women's own reasons? A critical review.

Inoue K, Barratt A, Richters J.

J Fam Plann Reprod Health Care. 2015 Oct;41(4):292-9. doi: 10.1136/jfprhc-2014-100976. Epub 2015 Jan 20. Review.

PMID:
25605480
39.

A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.

Barratt A, Irwig L, Glasziou P.

Int J Cancer. 2015 May 15;136(10):2486. doi: 10.1002/ijc.29270. Epub 2014 Nov 18. No abstract available.

40.

Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid.

Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Jacklyn G, Thornton H, Dhillon H, McCaffery K.

BMJ Open. 2014 Sep 25;4(9):e006016. doi: 10.1136/bmjopen-2014-006016.

41.

The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.

Hersch J, Barratt A, Jansen J, Houssami N, Irwig L, Jacklyn G, Dhillon H, Thornton H, McGeechan K, Howard K, McCaffery K.

BMJ Open. 2014 May 15;4(5):e004990. doi: 10.1136/bmjopen-2014-004990.

42.

A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.

Mathieu E, Herbert RD, McGeechan K, Herbert JJ, Barratt AL.

J Clin Epidemiol. 2014 Jun;67(6):667-71. doi: 10.1016/j.jclinepi.2014.02.001. Erratum in: J Clin Epidemiol. 2015 Jun;68(6):724.

PMID:
24767518
43.

Combination versus sequential single agent chemotherapy for metastatic breast cancer.

Dear RF, McGeechan K, Jenkins MC, Barratt A, Tattersall MH, Wilcken N.

Cochrane Database Syst Rev. 2013 Dec 18;(12):CD008792. doi: 10.1002/14651858.CD008792.pub2. Review.

PMID:
24347031
44.

Online prostate cancer screening decision aid for at-risk men: a randomized trial.

Watts KJ, Meiser B, Wakefield CE, Barratt AL, Howard K, Cheah BC, Mann GJ, Lobb EA, Gaff CL, Patel MI.

Health Psychol. 2014 Sep;33(9):986-97. doi: 10.1037/a0034405. Epub 2013 Nov 25.

PMID:
24274808
45.

Expanding the evidence on cancer screening: the value of scientific, social and ethical perspectives.

Rychetnik L, Carter SM, Barratt A, Irwig L.

Med J Aust. 2013 Jun 3;198(10):536-9.

PMID:
23725267
46.

Enhancing citizen engagement in cancer screening through deliberative democracy.

Rychetnik L, Carter SM, Abelson J, Thornton H, Barratt A, Entwistle VA, Mackenzie G, Salkeld G, Glasziou P.

J Natl Cancer Inst. 2013 Mar 20;105(6):380-6. doi: 10.1093/jnci/djs649. Epub 2013 Feb 1.

PMID:
23378639
47.

Women's views on overdiagnosis in breast cancer screening: a qualitative study.

Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, Dhillon H, McCaffery K.

BMJ. 2013 Jan 23;346:f158. doi: 10.1136/bmj.f158.

48.

Identifying and prioritising gaps in colorectal cancer trials research in Australia.

Dear RF, Barratt AL, Evans A, Simes J, Newsom J, Kent D, Crossing S, Holliday C, Segelov E, Hruby G, Tattersall MH.

Med J Aust. 2012 Nov 5;197(9):507-11.

PMID:
23121587
49.

Internet trials: participant experiences and perspectives.

Mathieu E, Barratt A, Carter SM, Jamtvedt G.

BMC Med Res Methodol. 2012 Oct 23;12:162. doi: 10.1186/1471-2288-12-162.

50.

Internet-based randomized controlled trials: a systematic review.

Mathieu E, McGeechan K, Barratt A, Herbert R.

J Am Med Inform Assoc. 2013 May 1;20(3):568-76. doi: 10.1136/amiajnl-2012-001175. Epub 2012 Oct 13. Review.

Supplemental Content

Loading ...
Support Center